| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akoya Biosciences, Inc. | Director | Common Stock | 0 | $0 | $1.16 | 08 Jul 2025 | Indirect |
| Akoya Biosciences, Inc. | Director | Common Stock | 0 | $0 | $1.16 | 08 Jul 2025 | Thomas A. Raffin Living Trust dated March 29, 2017 |
| LUMOS PHARMA, INC. | Director | Common Stock | 0 | $0 | $1.89 | 12 Dec 2024 | Direct |
| Akoya Biosciences, Inc. | Director | Stock Option (right to buy) | 0 | 08 Jul 2025 | Direct | ||
| LUMOS PHARMA, INC. | Director | Stock Option (Right to Buy) | 0 | 12 Dec 2024 | Direct |